The impact of signaling pathways stimulated by HER2 receptor on prediction of clinical outcome in metastatic breast cancer patients treated with trastuzumab

被引：0
|
作者：
Grell, P.
Svoboda, M.
Fabian, P.
Radova, L.
Dziechciarkova, M.
Palacova, M.
Nenutil, R.
Hajduch, M.
Vyzula, R.
机构：
[1] Masaryk Mem Canc Inst, Brno, Czech Republic
[2] Tomas Bata Univ Zlin, Zlin, Czech Republic
[3] Palacky Univ, CR-77147 Olomouc, Czech Republic
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.1048
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1048
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Akt expression and compartmentalization in prediction of clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab
    Grell, Peter
    Fabian, Pavel
    Khoylou, Marta
    Radova, Lenka
    Slaby, Ondrej
    Hrstka, Roman
    Vyzula, Rostislav
    Hajduch, Marian
    Svoboda, Marek
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 41 (04) : 1204 - 1212
  • [2] The impact of Ras/MAPK/S6K signaling pathway on prediction of clinical outcome in metastatic Her-2 positive breast cancer patients treated with trastuzumab
    Svoboda, Marek
    Khoylou, Marta
    Grell, Peter
    Navratil, Jiri
    Fabian, Pavel
    Juracek, Jaroslav
    Palacova, Marketa
    Vyzula, Rostislav
    Hajduch, Marian
    CANCER RESEARCH, 2014, 74 (19)
  • [3] SURVIVAL AND CARDIOTOXICITY FOR PATIENTS WITH HER2 POSITIVE, METASTATIC BREAST CANCER TREATED WITH TRASTUZUMAB IN ROUTINE CLINICAL PRACTICE
    Vasista, Anuradha
    Ryan, Luke
    Wilcken, Nicholas
    Moylan, Eugene
    Stockler, Martin
    Kiely, Belinda
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 146 - 147
  • [4] Clinical outcome of treatment without trastuzumab in HER2 positive breast cancer patients
    Aye, T. T.
    Mon, S.
    Khine, M.
    Sein, N.
    Thant, N. M.
    Win, A. K.
    Aung, E. P. P.
    Hnin, P. T.
    ANNALS OF ONCOLOGY, 2019, 30
  • [5] Cardiotoxicity in HER2 positive breast cancer patients treated with trastuzumab
    Lopez, M.
    Minguito Carazo, C.
    Delgado Sillero, I.
    Rojas Piedra, M.
    Tavara Silva, B.
    Lopez-Gonzalez, A.
    Castanon Lopez, C.
    Nieto Mangudo, B.
    Pedraza Lorenzo, M.
    Rodriguez Sanchez, A.
    Diz Tain, P.
    De Sande Gonzalez, L. M.
    Medina Valdivieso, S.
    Lopez Gonzalez, L.
    Honrado Franco, E.
    Garcia-Palomo, A.
    Sanchez-Cousido, L. F.
    ANNALS OF ONCOLOGY, 2020, 31 : S332 - S332
  • [6] Long-term outcome of HER2 positive metastatic breast cancer patients treated with first-line trastuzumab
    Yeo, B.
    Kotsori, K.
    Mohammed, K.
    Walsh, G.
    Smith, I. E.
    BREAST, 2015, 24 (06): : 751 - 757
  • [7] HER2 testing in a population-based study of patients with metastatic breast cancer treated with trastuzumab
    O'Malley, Frances P.
    Thomson, Tom
    Julian, Jim
    Have, Cherry
    Crosby, Roxanne
    Gelmon, Karen
    Andrulis, Irene
    Whelan, Tim
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2008, 132 (01) : 61 - 65
  • [8] Impact of Serum HER2 Extracellular Domain in Metastatic Breast Cancer Patients Treated with Trastuzumab Deruxtecan (T-DXd)
    Nozawa, Kazuki
    Kusudo, Maho
    Kureyama, Nari
    Nakakami, Akira
    Komaki, Rie
    Endo, Yuka
    Kataoka, Ayumi
    Kotani, Haruru
    Yoshimura, Akiyo
    Hattori, Masaya
    Sawaki, Masataka
    Iwata, Hiroji
    CANCER RESEARCH, 2024, 84 (09)
  • [9] mRNA expression of specific HER ligands and their association with clinical outcome in patients with metastatic breast cancer treated with trastuzumab
    Rapti, Vassiliki
    Moirogiorgou, Evangelia
    Koliou, Georgia-Angeliki
    Papadopoulou, Kyriaki
    Binas, Ioannis
    Pentheroudakis, George
    Bafaloukos, Dimitrios
    Bobos, Mattheos
    Chatzopoulos, Kyriakos
    Chrisafi, Sofia
    Christodoulou, Christos
    Nicolaou, Irene
    Sotiropoulou, Maria
    Magkou, Christina
    Koutras, Angelos
    Papakostas, Pavlos
    Kotsakis, Athanasios
    Razis, Evangelia
    Psyrri, Amanda
    Tryfonopoulos, Dimitrios
    Pectasides, Dimitrios
    Res, Eleni
    Alexopoulos, Athanasios
    Kotoula, Vassiliki
    Fountzilas, George
    ONCOLOGY LETTERS, 2022, 23 (01)
  • [10] HER-3 status by immunohistochemistry in HER-2-positive metastatic breast cancer patients treated with trastuzumab: correlation with clinical outcome
    Gori, Stefania
    Foglietta, Jennifer
    Mameli, Maria Grazia
    Stocchi, Lucia
    Fenocchio, Daniela
    Anastasi, Paola
    Iacono, Daniela
    Del Sordo, Rachele
    Basurto, Carlo
    De Angelis, Verena
    Sidoni, Angelo
    TUMORI, 2012, 98 (01) : 39 - 44
12345